FDA Modernization Act 2.0 Paves the Way to Computational Biology and Clinical Trials in a Dish.
作者信息
Ahmed Syed Mukhtar, Shivnaraine Rabindra V, Wu Joseph C
机构信息
Stanford Cardiovascular Institute, Stanford, CA (S.M.A., J.C.W.).
Greenstone Biosciences, Palo Alto, CA (S.M.A., R.V.S.).
出版信息
Circulation. 2023 Jul 25;148(4):309-311. doi: 10.1161/CIRCULATIONAHA.123.065585. Epub 2023 Jul 24.
Abstract
摘要
相似文献
1
FDA Modernization Act 2.0 Paves the Way to Computational Biology and Clinical Trials in a Dish.
Circulation. 2023 Jul 25;148(4):309-311. doi: 10.1161/CIRCULATIONAHA.123.065585. Epub 2023 Jul 24.
2
Next-Gen Therapeutics: Pioneering Drug Discovery with iPSCs, Genomics, AI, and Clinical Trials in a Dish.
Annu Rev Pharmacol Toxicol. 2025 Jan;65(1):71-90. doi: 10.1146/annurev-pharmtox-022724-095035. Epub 2024 Dec 17.
3
FDA Modernization Act 2.0: An insight from nondeveloping country.
Drug Dev Res. 2023 Dec;84(8):1572-1577. doi: 10.1002/ddr.22108. Epub 2023 Aug 17.
4
Clinical Trials in a Dish.
Trends Pharmacol Sci. 2017 Jan;38(1):4-7. doi: 10.1016/j.tips.2016.10.009. Epub 2016 Nov 19.
5
Clinical Trial in a Dish for Space Radiation Countermeasure Discovery.
Life Sci Space Res (Amst). 2022 Nov;35:140-149. doi: 10.1016/j.lssr.2022.05.006. Epub 2022 May 27.
6
Human Pluripotent Stem-Cell-Derived Models as a Missing Link in Drug Discovery and Development.
Pharmaceuticals (Basel). 2021 May 30;14(6):525. doi: 10.3390/ph14060525.
7
Pluripotent stem cells: the last 10 years.
Regen Med. 2016 Dec;11(8):831-847. doi: 10.2217/rme-2016-0117. Epub 2016 Dec 2.
8
Realizing the promise of the US Food and Drug Administration Modernization Act.
Clin Ther. 1998;20 Suppl C:C26-31. doi: 10.1016/s0149-2918(98)80005-2.
9
Human stem cell-derived oligodendrocytes: From humanized animal models to cell therapy in myelin diseases.
Semin Cell Dev Biol. 2021 Aug;116:53-61. doi: 10.1016/j.semcdb.2020.09.011. Epub 2020 Oct 17.
10
Application of Computational Biology and Artificial Intelligence in Drug Design.
Int J Mol Sci. 2022 Nov 5;23(21):13568. doi: 10.3390/ijms232113568.
引用本文的文献
1
Optimal dosing of anti-cancer treatment under drug-induced plasticity.
NPJ Syst Biol Appl. 2025 Aug 25;11(1):98. doi: 10.1038/s41540-025-00571-5.
2
Response of human iPSC-cardiomyocytes to adrenergic drugs assessed by high-throughput pericellular oxygen measurements.
bioRxiv. 2025 Jul 3:2025.06.27.662066. doi: 10.1101/2025.06.27.662066.
3
Integrated Patient Digital and Biomimetic Twins for Precision Medicine: A Perspective.
Semin Liver Dis. 2025 Jul 23. doi: 10.1055/a-2649-1560.
4
Pericellular oxygen dynamics in human cardiac fibroblasts and iPSC-cardiomyocytes in high-throughput plates: insights from experiments and modeling.
J Mol Cell Cardiol Plus. 2025 Jun 11;13:100464. doi: 10.1016/j.jmccpl.2025.100464. eCollection 2025 Sep.
5
Translation of PET radiotracers for cancer imaging: recommendations from the National Cancer Imaging Translational Accelerator (NCITA) consensus meeting.
BMC Med. 2025 Jan 23;23(1):37. doi: 10.1186/s12916-024-03831-z.
6
Gelatin methacryloyl biomaterials and strategies for trophoblast research.
Placenta. 2024 Nov;157:67-75. doi: 10.1016/j.placenta.2024.09.016. Epub 2024 Sep 24.
7
Next-Gen Therapeutics: Pioneering Drug Discovery with iPSCs, Genomics, AI, and Clinical Trials in a Dish.
Annu Rev Pharmacol Toxicol. 2025 Jan;65(1):71-90. doi: 10.1146/annurev-pharmtox-022724-095035. Epub 2024 Dec 17.
8
Clinical trials in-a-dish for cardiovascular medicine.
Eur Heart J. 2024 Oct 21;45(40):4275-4290. doi: 10.1093/eurheartj/ehae519.
9
In vitro to in vivo extrapolation from 3D hiPSC-derived cardiac microtissues and physiologically based pharmacokinetic modeling to inform next-generation arrhythmia risk assessment.
Toxicol Sci. 2024 Sep 1;201(1):145-157. doi: 10.1093/toxsci/kfae079.
10
The new era of cardiovascular research: revolutionizing cardiovascular research with 3D models in a dish.
Med Rev (2021). 2024 Feb 20;4(1):68-85. doi: 10.1515/mr-2023-0059. eCollection 2024 Feb.
本文引用的文献
1
2022 FDA approvals.
Nat Rev Drug Discov. 2023 Feb;22(2):83-88. doi: 10.1038/d41573-023-00001-3.
2
Challenges and opportunities for the next generation of cardiovascular tissue engineering.
Nat Methods. 2022 Sep;19(9):1064-1071. doi: 10.1038/s41592-022-01591-3. Epub 2022 Sep 5.
3
Shifting machine learning for healthcare from development to deployment and from models to data.
Nat Biomed Eng. 2022 Dec;6(12):1330-1345. doi: 10.1038/s41551-022-00898-y. Epub 2022 Jul 4.
4
Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy.
Sci Transl Med. 2020 Jul 29;12(554). doi: 10.1126/scitranslmed.aax9276.
5
Elixirs, diluents, and the passage of the 1938 Federal Food, Drug and Cosmetic Act.
Ann Intern Med. 1995 Mar 15;122(6):456-61. doi: 10.7326/0003-4819-122-6-199503150-00009.
Zotero 插件